ID

45987

Description

Principal Investigator: Paul K. Paik, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA MeSH: Squamous Cell Carcinoma,Nonsmall Cell Lung Cancer https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000907 Putative oncogenic pathways in squamous cell lung cancer have been recently characterized, although their biologic repercussions in patients is largely unknown. This study sought to discover potential clinical manifestations of major pathways in squamous cell lung cancer, particularly the PI3K pathway. Two key findings emerged: patients with stage IV squamous cell lung cancer whose tumors harbored upstream PI3K aberrations had significantly worse survival and a higher burden of metastatic disease. In addition, brain metastases were significantly more common in these patients than in others. Paired lung primary/brain metastasis genotyping, including RNA sequencing and whole exome sequencing, uncovered a high degree of genetic heterogeneity between lung/brain pairs, and identified potential regulators of the metastatic process to brain.

Lien

dbGaP study=phs000907

Mots-clés

  1. 06/04/2024 06/04/2024 - Madita Rudolph
Détendeur de droits

Paul K. Paik, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Téléchargé le

6 avril 2024

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

dbGaP phs000907 Brain Metastases in Squamous Cell Lung Cancers

Eligibility Criteria

Inclusion and exclusion criteria
Description

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Inclusion criteria: 1) Signed an institutional biospecimen utilization protocol (MSK IRB 06-107) 2) Stage IV squamous cell lung cancer pathologic diagnosis 3) Availability of respected brain metastasis and lung primary tumor
Description

Elig.phs000907.v1.p1.1

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0021430
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C0149782
UMLS CUI [2,3]
C0441772
UMLS CUI [2,4]
C1521733
UMLS CUI [2,5]
C0011900
UMLS CUI [3,1]
C1512693
UMLS CUI [3,2]
C0470187
UMLS CUI [3,3]
C0220650
UMLS CUI [3,4]
C0242379
UMLS CUI [3,5]
C0475447

Similar models

Eligibility Criteria

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs000907.v1.p1.1
Item
Inclusion criteria: 1) Signed an institutional biospecimen utilization protocol (MSK IRB 06-107) 2) Stage IV squamous cell lung cancer pathologic diagnosis 3) Availability of respected brain metastasis and lung primary tumor
boolean
C1512693 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1512693 (UMLS CUI [2,1])
C0149782 (UMLS CUI [2,2])
C0441772 (UMLS CUI [2,3])
C1521733 (UMLS CUI [2,4])
C0011900 (UMLS CUI [2,5])
C1512693 (UMLS CUI [3,1])
C0470187 (UMLS CUI [3,2])
C0220650 (UMLS CUI [3,3])
C0242379 (UMLS CUI [3,4])
C0475447 (UMLS CUI [3,5])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial